Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
about
Mutation of the epidermal growth factor receptor gene and its impact on the efficacy of gefitinib in advanced non-small cell lung cance.Value of serum marker HE4 in pulmonary carcinoma diagnosisComparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung CancerSerum neuron specific enolase levels correlate with patient prognosis for advanced lung cancer.Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.
P2860
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@ast
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@en
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@nl
type
label
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@ast
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@en
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@nl
prefLabel
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@ast
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@en
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@nl
P2093
P2860
P356
P1476
Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
@en
P2093
Huanchen Guo
Xiuqin Hong
Zhidong Wang
P2860
P304
P356
10.2147/DDDT.S74259
P407
P577
2014-12-19T00:00:00Z